“Transparency” Continues to Drive New PBM Initiatives

A growing number of organizations that offer more transparent pharmacy benefit management services are entering the market.

Prime Therapeutics Introduces IntegratedRx™ – Oncology

Prime’s IntegratedRx™ – Oncology streamlines the treatment pathway for members who are fighting cancer to medications directly from their oncologist’s clinic or affiliated hospital pharmacy.

Walmart Health Targets Self-Insured Employers with Transcarent Agreement

To grow its services Walmart Health is focused on the needs of the patient and customer by creating partnerships, most recently with Transcarent, a new and different health and care experience company putting people back in charge of their health and care experiences

Trinity Life Sciences Expanding Life Sciences Commercialization Capabilities

Trinity Life Sciences (Trinity) has since grown to comprise a global team of advisors, technical experts, data integrators, and technology innovators. Trinity’s vision is to be the premier global life sciences commercialization partner, empowering clients to deliver life-changing therapies to patients

PANTHERx and Amber Specialty Pharmacy Selected by ChemoCentryx to Dispense Tavneos

ChemoCentryx selected only Amber Specialty Pharmacy and PANTHERx as its limited distribution network for Tavenos

Karmanos Cancer Center’s KSP Specialty Pharmacy Expands Services

The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) recently announced the launch of new services and a new website

Syneos Health Increases Data Analytics Capabilities with RxDataScience Acquisition

Syneos Health recently announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company

AllianceRx Walgreens Prime Dispensing Arcalyst and Gavreto

AllianceRx Walgreens Prime (AllianceRx) is offering Arcalyst (rilonacept) and Gavreto (pralsetinib), two medicines prescribed for the treatment of specific kinds of cancer as well as an autoinflammatory cardiovascular disease